Related references
Note: Only part of the references are listed.European cancer mortality predictions for the year 2019 with focus on breast cancer
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2019)
Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells
Mohamed E. M. Saeed et al.
PHYTOMEDICINE (2019)
A redox cycle meets insulin fibrillation in vitro
Haojie Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
Maximilian Stahl et al.
LEUKEMIA & LYMPHOMA (2019)
A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
Sara Abdelfatah et al.
JOURNAL OF ADVANCED RESEARCH (2019)
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
Keerthana Gnanapradeepan et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes
Marc Payton et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma/chronic lymphocytic leukaemia
Larissa Sena Teixeira Mendes et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
TCTP as a therapeutic target in melanoma treatment
M. Boia-Ferreira et al.
BRITISH JOURNAL OF CANCER (2017)
Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin
Ulrich-Axel Bommer et al.
CELL COMMUNICATION AND SIGNALING (2017)
Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses
Onat Kadioglu et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Cyclin-dependent kinase pathways as targets for women's cancer treatment
Gottfried E. Konecny
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2016)
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage
Ansar Karimian et al.
DNA REPAIR (2016)
Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells
Onat Kadioglu et al.
INVESTIGATIONAL NEW DRUGS (2016)
Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy
Ean-Jeong Seo et al.
ONCOTARGET (2016)
The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases
Shilun Zuo et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Regulation of the p53 response and its relationship to cancer
David W. Meek
BIOCHEMICAL JOURNAL (2015)
Expression and clinical role of TCTP in epithelial ovarian cancer
Chen Chen et al.
JOURNAL OF MOLECULAR HISTOLOGY (2015)
High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas
Pramila Ramani et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Jigang Wang et al.
NATURE COMMUNICATIONS (2015)
Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells
Maria Lucibello et al.
ONCOTARGET (2015)
Expression of Translationally Controlled Tumor Protein in Human Kidney and in Renal Cell Carcinoma
Maria R. Ambrosio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Targeting Oncogenic Mutant p53 for Cancer Therapy
Alejandro Parrales et al.
FRONTIERS IN ONCOLOGY (2015)
Targeted Efficacy of Dihydroartemisinin for Translationally Controlled Protein Expression in a Lung Cancer Model
Lian-Ke Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
TCTP as therapeutic target in cancers
Julie Acunzo et al.
CANCER TREATMENT REVIEWS (2014)
Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities
Bo Hong et al.
CURRENT DRUG TARGETS (2014)
Lessons from tumor reversion for cancer treatment
Robert Amson et al.
CURRENT OPINION IN ONCOLOGY (2013)
Cdks, cyclins and CKIs: roles beyond cell cycle regulation
Shuhui Lim et al.
DEVELOPMENT (2013)
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
Mayur V. Jain et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
TCTP/HRF pathway and angiogenesis: A feasible intercourse in chronic lymphocytic leukemia
Munci Yagci et al.
LEUKEMIA RESEARCH (2013)
TCTP overexpression is associated with the development and progression of glioma
Xia Miao et al.
TUMOR BIOLOGY (2013)
Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development
Tim Hon Man Chan et al.
HEPATOLOGY (2012)
Reciprocal repression between P53 and TCTP
Robert Amson et al.
NATURE MEDICINE (2012)
Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53
Seung Bae Rho et al.
FEBS LETTERS (2011)
Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells
Franck Bazile et al.
CARCINOGENESIS (2009)
The molecular programme of tumour reversion: the steps beyond malignant transformation
Adam Telerman et al.
NATURE REVIEWS CANCER (2009)
Translationally controlled tumor protein is a target of tumor reversion
M Tuynder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Biological models and genes of tumor reversion:: Cellular reprogramming through tpt1/TCTP and SIAH-1
M Tuynder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of translationally controlled tumor protein mRNA in human colon cancer
S Chung et al.
CANCER LETTERS (2000)
Retinoids in chemoprevention and differentiation therapy
LA Hansen et al.
CARCINOGENESIS (2000)
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
J O'Brien et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
